About: In vivo comparison of DOTA based Ga-68-labelled bisphosphonates for bone imaging in non-tumour models     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
rdfs:seeAlso
Description
  • Bone metastases are a class of cancerous metastases that result from the invasion of a tumor into bone. The solid mass which forms inside the bone is often associated with a constant dull ache and severe spikes in pain, which greatly reduce the quality of life of the patient. Numerous Tc-88m-labeled bisphosphonate functionalised complexes are well established tracers for bone metastases imaging. The objective of this research was to evaluate the pharmacokinetics and behaviour of three DOTA based bisphosphonate functionalised ligands (BPAMD, BPAPD and BPPED), using both Ga-68 mu-PET in vivo imaging and ex vivo biodistribution studies in healthy Wistar rats. The compounds were labelled with Ga-68 in high yields using an ammonium acetate buffer, and subsequently purified using a cation exchange resin. High bone uptake values were observed for all Ga-68-labelled bisphosphonates at 60 minutes p.i. The highest uptake was observed for [Ga-68]BPPED (2.6 +/- 0.3% ID/g) which compares favourably with that of [Tc-99m]MDP (2.7 +/- 0.1 ID/g) and [F-18]fluoride (2.4 +/- 0.2% ID/g). The Ga-68-labelled DOTA-bisphosphonates showed rapid clearance from the blood and renal system, as well as low binding to soft tissue, resulting in a high bone to blood ratio (9.9 at 60 minutes p.i. for [Ga-68]BPPED, for example). Although further studies are required to assess their performance in tumor models, the results obtained suggest that these ligands could be useful both in imaging (Ga-68) and therapeutic treatment (Lu-177) of bone metastases.
  • Bone metastases are a class of cancerous metastases that result from the invasion of a tumor into bone. The solid mass which forms inside the bone is often associated with a constant dull ache and severe spikes in pain, which greatly reduce the quality of life of the patient. Numerous Tc-88m-labeled bisphosphonate functionalised complexes are well established tracers for bone metastases imaging. The objective of this research was to evaluate the pharmacokinetics and behaviour of three DOTA based bisphosphonate functionalised ligands (BPAMD, BPAPD and BPPED), using both Ga-68 mu-PET in vivo imaging and ex vivo biodistribution studies in healthy Wistar rats. The compounds were labelled with Ga-68 in high yields using an ammonium acetate buffer, and subsequently purified using a cation exchange resin. High bone uptake values were observed for all Ga-68-labelled bisphosphonates at 60 minutes p.i. The highest uptake was observed for [Ga-68]BPPED (2.6 +/- 0.3% ID/g) which compares favourably with that of [Tc-99m]MDP (2.7 +/- 0.1 ID/g) and [F-18]fluoride (2.4 +/- 0.2% ID/g). The Ga-68-labelled DOTA-bisphosphonates showed rapid clearance from the blood and renal system, as well as low binding to soft tissue, resulting in a high bone to blood ratio (9.9 at 60 minutes p.i. for [Ga-68]BPPED, for example). Although further studies are required to assess their performance in tumor models, the results obtained suggest that these ligands could be useful both in imaging (Ga-68) and therapeutic treatment (Lu-177) of bone metastases. (en)
Title
  • In vivo comparison of DOTA based Ga-68-labelled bisphosphonates for bone imaging in non-tumour models
  • In vivo comparison of DOTA based Ga-68-labelled bisphosphonates for bone imaging in non-tumour models (en)
skos:prefLabel
  • In vivo comparison of DOTA based Ga-68-labelled bisphosphonates for bone imaging in non-tumour models
  • In vivo comparison of DOTA based Ga-68-labelled bisphosphonates for bone imaging in non-tumour models (en)
skos:notation
  • RIV/00216208:11310/13:10139597!RIV14-MSM-11310___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I, Z(MSM0021620857)
http://linked.open...iv/cisloPeriodika
  • 6
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 79416
http://linked.open...ai/riv/idVysledku
  • RIV/00216208:11310/13:10139597
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • bisphosphonates; DOTA; Lu-177; PET; Ga-68; bone metastases (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • NL - Nizozemsko
http://linked.open...ontrolniKodProRIV
  • [EF84EA0D9C3A]
http://linked.open...i/riv/nazevZdroje
  • Nuclear Medicine and Biology
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 40
http://linked.open...iv/tvurceVysledku
  • Kubíček, Vojtěch
  • Rösch, Frank
  • Fellner, Marco
  • Bergmann, Ralf
  • Meckel, Marian
  • Thieme, Natalie
http://linked.open...ain/vavai/riv/wos
  • 000323087200014
http://linked.open...n/vavai/riv/zamer
issn
  • 0969-8051
number of pages
http://bibframe.org/vocab/doi
  • 10.1016/j.nucmedbio.2013.04.012
http://localhost/t...ganizacniJednotka
  • 11310
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 37 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software